DOCSLIB.ORG

Everbright Securities Company Limited 光大證券股份有限公司 (A Joint Stock Company Incorporated in the People’S Republic of China with Limited Liability) (Stock Code: 6178)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Everbright Securities Company Limited 光大證券股份有限公司 (A Joint Stock Company Incorporated in the People’S Republic of China with Limited Liability) (Stock Code: 6178) Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. Everbright Securities Company Limited 光大證券股份有限公司 (A joint stock company incorporated in the People’s Republic of China with limited liability) (Stock Code: 6178) NOMINATION OF CANDIDATES FOR THE DIRECTORS OF THE FIFTH SESSION OF THE BOARD OF DIRECTORS AND NOMINATION OF CANDIDATES FOR THE SUPERVISORS OF THE FIFTH SESSION OF THE SUPERVISORY COMMITTEE The board (the “Board”) of directors (the “Directors”) of Everbright Securities Company Limited (the “Company”) hereby announces that in view of the requirements of the Articles of Association of the Company (the “Articles of Association”), the Board and the supervisory (the “Supervisors”) committee of the Company (the “Supervisory Committee”) proposed to carry out the re-election and appointment of their members. On August 29, 2017, the 31st meeting of the fourth session of the Board approved the resolution regarding the proposed nomination of Mr. Gao Yunlong, Mr. Ge Haijiao, Mr. Xue Feng, Mr. Ju Hao, Mr. Yin Lianchen, Mr. Chan Ming Kin, Mr. Xu Jingchang, Mr. Xiong Yan, Mr. Li Zheping and Mr. Au Sing Kun as the candidates for the Directors of the fifth session of the Board for election at the 2017 fourth extraordinary general meeting (the “EGM”). On August 29, 2017, the 17th meeting of the fourth session of the Supervisory Committee approved the resolution regarding the proposed nomination of Mr. Liu Jiping, Mr. Zhang Jingcai, Mr. Wang Hongyang, Mr. Zhu Wuxiang and Mr. Zhang Limin as the candidates for the Supervisors of the fifth session of the Supervisory Committee for election at the EGM. I. Nomination OF Candidates FOR THE Directors OF THE FIFTH SESSION OF THE Board Pursuant to the consideration and approval by the remuneration, nomination and credentials committee of the Company and the consideration and approval at the 31st meeting of the fourth session of the Board held on August 29, 2017, the candidates for the Directors of the fifth session of the Board proposed and nominated by the Board are as follows: • Mr. Gao Yunlong (non-executive Director) • Mr. Ge Haijiao (non-executive Director) • Mr. Xue Feng (executive Director) • Mr. Ju Hao (non-executive Director) • Mr. Yin Lianchen (non-executive Director) 1 • Mr. Chan Ming Kin (non-executive Director) • Mr. Xu Jingchang (independent non-executive Director) • Mr. Xiong Yan (independent non-executive Director) • Mr. Li Zheping (independent non-executive Director) • Mr. Au Sing Kun (independent non-executive Director) The above candidates for the Directors of the fifth session of the Board will be considered and approved at the EGM to form the fifth session of the Board. The biographies of the above candidates for the Directors of the fifth session of the Board and other information related to their appointments are set out in the Appendix I to this announcement. The Articles of Association provides that the Board shall comprise 13 members. After being considered and approved by the EGM, the aforesaid candidates for Directors shall form the fifth session of the Board and the three other candidates for Directors remain to be nominated in accordance with the relevant procedures. Following the expiry of the term of the current session of the Board on September 15, 2017, the relevant Directors shall continue to perform their duties before the candidates for the Directors being elected at the EGM and having obtained the relevant qualifications for their positions. Except for Mr. Ju Hao, the aforementioned candidates for the Directors have obtained the qualifications for their positions in accordance with the Administrative Measures for Qualifications of Directors, Supervisors and Senior Management of Securities Companies (《證券公司董事、監事和高級管理人員任職資格監管辦法》). The qualification of the position of Mr. Ju Hao is subject to approval. If appointed, the aforementioned proposed Directors will enter into Director’s service agreements with the Company, with their term of office commencing on the date when the resolutions on their respective appointments as Directors are approved at the EGM and ending on the expiry of the term of the fifth session of the Board, and they shall be eligible for re-election and re-appointment upon the expiry of the term. The remuneration of the executive Directors is determined by the remuneration system of the Company, and the remuneration, nomination and credentials committee of the Company is responsible for considering the annual performance-based compensation distribution plan of the management and submitting the same to the Board for final approval. The non-executive Directors do not receive remuneration from the Company. The annual remuneration of the independent non-executive Directors is expected to be RMB100,000 (tax exclusive). 2 To the best knowledge of the Directors and save as disclosed in this announcement, the aforementioned proposed Directors did not hold any directorship in the last three years in any other public companies, the securities of which are listed on any securities market in Hong Kong or overseas; and they do not have any relationship with any Director, Supervisor, senior management or substantial or controlling shareholder of the Company and their respective subsidiaries nor do they hold any position with the Company or any of its subsidiaries. None of the aforementioned proposed Directors has any interest in any shares of the Company or its associated corporations within the meaning of Part XV of the Securities and Futures Ordinance (Cap. 571 of the laws of Hong Kong) as at the date of this announcement. Save as disclosed in this announcement, the aforementioned proposed Directors have confirmed that there is no information that is required to be disclosed pursuant to the requirements set out in Rules 13.51(2) (h) to (v) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the “Listing Rules”), nor is there any matter that needs to be brought to the attention of the shareholders of the Company. They have also confirmed that they have not been subject to any penalty by the China Securities Regulatory Commission (“CSRC”) or other related departments or punishment by any stock exchanges. Mr. Xu Jingchang, Mr. Xiong Yan, Mr. Li Zheping and Mr. Au Sing Kun as candidates for independent non-executive Directors have confirmed their independence to the Company in accordance with Rule 3.13 of the Listing Rules. The Board is also of the view that each of them meets the independence guidelines set out in Rule 3.13 of the Listing Rules and is independent pursuant to the terms thereof. II. Nomination OF Candidates FOR THE Supervisors OF THE FIFTH SESSION OF THE Supervisory COMMITTEE The Company convened the 17th meeting of the fourth session of the Supervisory Committee on August 29, 2017 at which the resolution regarding the election of members of the fifth session of the Supervisory Committee of the Company was considered and approved. Mr. Liu Jiping, Mr. Zhang Jingcai, Mr. Wang Hongyang, Mr. Zhu Wuxiang and Mr. Zhang Limin were nominated as candidates for the Supervisors of the fifth session of the Supervisory Committee and list of these candidates will be proposed to the EGM for consideration and approval. The above candidates for the Supervisors for the fifth session of the Supervisory Committee will be considered and approved at the EGM. The biographies of the above candidates for the Supervisors for the fifth session of the Supervisory Committee and other information related to their appointments are set out in the Appendix II to this announcement. The aforementioned candidates for the Supervisors have obtained the qualifications for their positions in accordance with the Administrative Measures for Qualifications of Directors, Supervisors and Senior Management of Securities Companies (《證券公司董事、監事和高級 管理人員任職資格監管辦法》). 3 If appointed, the aforementioned proposed Supervisors will enter into service agreements with the Company, with their term of office commencing on the date when the resolutions on their respective appointments as Supervisors are approved at the EGM and ending on the expiry of the term of the fifth session of the Supervisory Committee, and they shall be eligible for re-election and re-appointment upon expiry of the term. The remuneration of the chief supervisor is determined in accordance with the remuneration system of the Company, and the remuneration, nomination and credentials committee of the Company is responsible for considering the annual performance-based compensation distribution plan of the management and submitting the same to the Board for final approval. The remuneration of the employee Supervisors is determined in accordance with the remuneration system of the Company, which is closely linked to the position and performance of the individual. The annual remuneration of the external Supervisors is expected to be RMB70,000 (tax exclusive). To the best knowledge of the Directors and save as disclosed in this announcement, the aforementioned proposed Supervisors did not hold any directorship in the last three years in any other public companies, the securities of which are listed on any securities market in Hong Kong or overseas; and they do not have any relationship with any director, supervisor, senior management or substantial or controlling shareholder of the Company or their respective subsidiaries nor do they hold any position with the Company or any of its subsidiaries. None of the aforementioned proposed Supervisors has any interest in any shares of the Company or its associated corporations within the meaning of Part XV of the Securities and Futures Ordinance (Cap.571 of the laws of Hong Kong) as at the date of this announcement.
Load more

Recommended publications
  • Board of Director's Operating Report for Financial Statement At
    Board of Director’s Operating Report for Financial Statement at December 31, 2008 126 Financial Statement 2008 - Management Report Shareholders, The 2008 financial statements, prepared on the basis of IAS/IFRS international accounting standards, report on your company’s twenty-eighth year in business, closing with a profit of 21.2 million euro (+ 18.7% over 2007), after payment of 7.8 million Euro in taxes. R.O.E. was 27.40%, significantly higher than in 2007 (24.05%). On the topic of competitive positioning, note that in 2008 the company ranked fifth in its sector in terms of outstanding credit, with a market share of 6.0%, and fourth in terms of advances and payments made, with a market share of 6.7% (source: Assifact). The annual profit, though it did reflect the effects of certain non-recurrent events, is definitely noteworthy in terms of management of regular operations. In the year 2008 profit margins reflected replacement of about 3.0 million Euro in gains from purchases of credit not at face value (now a residual activity), which were entered under “Other operating income” in 2007, with profit margins from characteristic operations, marking the completion of the commercial strategy undertaken since 2006 aiming to improve performance on the working capital market for customer companies, the number of which has definitely grown (+ 43% active transferring customers). The Operating Margin was 49.2 million euro, up 12.4% over 2007. This performance is primarily attributable to Interest Margin dynamics, which have settled at 34.0 million euro (+26.4% over 2007), while Net Commissions were worth 15.2 million euro (-10.0 % since 2007).
    [Show full text]
  • PEI 300 Guess Who’S Back on Top?
    Issue 165 | May 2018 | privateequityinternational.com PEI 300 Guess who’s back on top? THE ORACLE SPEAKS David Rubenstein on the future of private capital SECONDARIES ROUNDTABLE Keeping LPs front and centre WHY PRIVATE EQUITY? The asset allocation special PLUS: the PEI Q1 Fundraising Report; IRRs vs money multiples; introducing the CEPRES model portfolio; Texas TRS goes Canadian; inside the PE retail blowouts; and much more… Equistone announced the successful final We are one of close of Fund VI at its €2.8bn hard cap in March 2018. Europe’s most Equistone has made three investments for Fund VI and will continue to source deals active mid-market and build value with management teams across our target markets. investors. www.equistonepe.com Evercore acted as the exclusive global placement agent for Equistone Partners Europe Fund VI. © EQUISTONE PARTNERS EUROPE LIMITED Authorised and regulated by The Financial Conduct Authority. PE International Ad May 2018.indd 1 18/04/2018 15:18 Riding high historically it’s been successful, but it needs to ISOBEL ISSN 1474–8800 | ISSUE 165 | MARKHAM work hard to avoid becoming a victim of that MAY 2018 EDITOR'S success. The signs are already there that this LETTER is starting to happen. Senior Editor, Private Equity Toby Mitchenall Tel: +44 207 566 5447 Sandra Robertson, chief investment officer [email protected] and chief executive of the UK’s £3 billion ($4.3 Americas Editor, Private Equity Marine Cole billion; €3.4 billion) Oxford University Endow- Tel: +1 212 633 1455 [email protected] ment
    [Show full text]
  • Interim Report for the Six Months Ended 30 June 2008
    China Everbright Limited 中國光大控股有限公司 (Stock Code: 165) Interim Report For the six months ended 30 June 2008 簡單成就價值 Making Wealth Simple BOARD OF DIRECTORS Tang Shuangning Chairman Zang Qiutao Deputy Chairman Chen Shuang Chief Executive Officer Tang Chi Chun, Richard Chief Financial Officer + Wang Weimin * Ng Ming Wah, Charles * Seto Gin Chung, John * Lin Zhijun + Non-executive Director * Independent Non-executive Directors COMPANY SECRETARY LEGAL ADVISOR Chan Ming Kin Messrs. Wilkinson & Grist REGISTERED OFFICE SHARE REGISTRARS Room 4001, 40th Floor Tricor Secretaries Limited Far East Finance Centre 26th Floor, Tesbury Centre 16 Harcourt Road 28 Queen’s Road East Hong Kong Wanchai Hong Kong PRINCIPAL BANKERS AUDITORS Standard Chartered Bank (Hong Kong) Limited KPMG Bank of Communications Company, Limited Fubon Bank (Hong Kong) Limited Hang Seng Bank Limited WEBSITE ADDRESS http://www.everbright165.com.hk STOCK CODE: 165 China Everbright Limited Interim Report 2008 1 INTERIM RESULTS The Directors of China Everbright Limited (the “Company”) are pleased to announce the unaudited results of the Company and its subsidiaries (the “Group”) for the six months ended 30 June 2008. The interim financial report is prepared on a basis consistent with the accounting policies and methods adopted in the 2007 audited accounts. The interim financial report is unaudited, but has been reviewed by KPMG, in accordance with Hong Kong Standard on Review Engagements 2410, “Review of interim financial information performed by the independent auditor of the entity” issued by the Hong Kong Institute of Certified Public Accountants, KPMG’s review report to the Board of Directors of the Company is included on page 23.
    [Show full text]
  • Life Sciences and Healthcare
    Life Sciences and Healthcare Beijing Guangzhou Hong Kong Shanghai Shenzhen 27/F, North Tower 17/F, International Finance 26/F, One Exchange Square 24/F, HKRI Centre Two, 17/F, Tower One, Kerry Plaza Beijing Kerry Centre Place, 8 Huaxia Road, 8 Connaught Place, Central HKRI Taikoo Hui 1 Zhong Xin Si Road 1 Guanghua Road Zhujiang New Town Hong Kong 288 Shi Men Yi Road Futian District Chaoyang District Guangzhou 510623, China Shanghai 200041, China Shenzhen 518048, China Beijing 100020, China Tel: +86 10 5769 5600 Tel: +86 20 3225 3888 Tel: +852 3976 8888 Tel: +86 21 2208 1166 Tel: +86 755 8159 3999 Fax:+86 10 5769 5788 Fax:+86 20 3225 3899 Fax:+852 2110 4285 Fax:+86 21 5298 5599 Fax:+86 755 8159 3900 www.fangdalaw.com Life Sciences and Healthcare Life Sciences and Healthcare 01 The Preeminent China-based International Law Firm Founded in 1993 and one of the most prestigious law firms Our service to clients is premised on the dual foundations in the region, Fangda Partners has over 700 lawyers. We of strong local law capabilities and a global business outlook. serve a wide variety of major clients – including large MNCs, Our lawyers are qualified in many jurisdictions, including global financial institutions, leading Chinese enterprises the People's Republic of China, Hong Kong SAR, England and fast-growing Hi-tech companies – on an extensive range and Wales, the United States, Singapore and Australia. of commercial matters through our network offices in Beijing, Guangzhou, Hong Kong, Shanghai and Shenzhen, Our understanding of the laws and processes in major offering PRC law and Hong Kong law.
    [Show full text]
  • Everbright Investment Conference 2014 Held in Xiamen
    Everbright Investment Conference 2014 held in Xiamen More than 350 investors and industry experts participate to discuss investment opportunities exhibited locally and abroad On 29-31 October 2014, China Everbright Limited (“Everbright”, stock code: 165.HK) held the Everbright Investment Conference 2014 in Xiamen to explore the current economic development trends in China as well as investment opportunities and challenges China faces in the asset management industry, attracting a total of more than 350 investors and industry experts to participate in it. “Venturing Beyond Your Horizon” was the theme for the Investment Conference. Industry experts congregated to discuss the in-depth development trend of China’s economy and the asset management industry as well as to provide a comprehensive analysis of where China is situated in the global asset management market and the challenges to overcome. They explored how China can advance in the international capital market as well as further grasp global investment opportunities and to discover how to attract overseas capital into the Chinese market to further spring the momentum of China’s economic development. The conference began with a welcome remarks and opening speech by Everbright’s Executive Director and CEO Mr. Chen Shuang, followed by a keynote speech by Deputy General Manager of China Everbright Group Limited and Deputy Chairman of the Board of Directors of China Everbright Limited Dr. Liu Jun, and The National Council for Social Security Fund’s Vice-Chairman, Mr. Wang Zhongmin, talking about financial crisis and risk management as well as the economic ecosystem of internet investment. Mr. Chen Shuang, together with Sequoia Capital China’s Founding Managing Partner, Mr.
    [Show full text]
  • View Annual Report
    STEALTH BIOTHERAPEUTICS CORP FORM 20-F (Annual and Transition Report (foreign private issuer)) Filed 04/04/19 for the Period Ending 12/31/18 Telephone 617-600-6888 CIK 0001696396 Symbol MITO SIC Code 2834 - Pharmaceutical Preparations Industry Biotechnology & Medical Research Sector Healthcare Fiscal Year 12/31 http://www.edgar-online.com © Copyright 2020, EDGAR Online, a division of Donnelley Financial Solutions. All Rights Reserved. Distribution and use of this document restricted under EDGAR Online, a division of Donnelley Financial Solutions, Terms of Use. Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of event requiring this shell company report Commission file number: 001-38810 STEALTH BIOTHERAPEUTICS CORP (Exact name of Registrant as specified in its charter) N/A (Translation of Registrant’s name into English) Cayman Islands (Jurisdiction of incorporation) Stealth BioTherapeutics Corp c/o Intertrust Corporate Services (Cayman) Limited 190 Elgin Avenue, George Town Grand Cayman KY1-9005 Cayman Islands (address of principal
    [Show full text]
  • 2015 Annual Report of the Company
    NEW NORMAL NEW EQUILIBRIUM 新常態 新平衡 annual report 2015 stock code: 165 SERVICE PHILOSOPHY MAKING WEALTH SIMPLE We adhere to our service philosophy with sound corporate governance, professionalism and tailored financial solutions, helping our clients create wealth and value with ease. COVER STORY Yoga focuses on breathing, meditation and thinking calm thoughts. Yoga helps its practitioners feel more relaxed, balanced and, more importantly, stronger. Faced with a complex external environment, CEL’s made structural readjustments and vigorously sought to optimize its business operations across various segments, with long-term perspective, achieving a much stronger “new balance” under the “new normal”. CONTENTS Company Overview 008 Corporate Strategy 009 2015 Results Highlights 010 2015 Review 014 Chairman’s Statement 020 Management Discussion and Analysis 022 Corporate Social Responsibility Report 050 Corporate Governance Report 062 Risk Management Report 084 Directors’ Report 092 Directors and Senior Management 104 Independent Auditor’s Report 108 Consolidated Statement of Profit or Loss 110 Consolidated Statement of Comprehensive Income 111 Consolidated Statement of Financial Position 112 Consolidated Statement of Changes in Equity 114 Consolidated Cash Flow Statement 115 Notes to the Financial Statements 117 Financial Summary 193 Particulars of Major Properties 194 Corporate Information Inside back cover DISCIPLINED Our disciplined approach and long-term perspective set the stage. We are sharply focused on delivering excellent performance in investment and fund management, being responsible stewards of our investors’ capital, managing risk and seeking new opportunities. PACE Global scale, optimal fundraising structure and diversity across real estate markets allow us to identify relative value and move capital to the most attractive opportunities, with a more elastic portfolio.
    [Show full text]
  • Annual Report 2018
    COVT ER S ORY O PPORTUNITIES IN DISRUPTION The financial markets in 2018 were dynamic with challenges and game-changing moments like a volleyball match. Steady performance, professional skills and a cohesive team are the basics and core competencies of the greatest teams as well as leading financial institutions. But to win and stand out among their peers, the team has to be responsive to changes on the court and be decisive, mastering tactics and adjusting strategies according to the environment. Building on the DNA of being STABLE and STRONG yet AGILE and INNOVATIVE, Everbright has demonstrated its capability to Master the Playbook and Embrace Opportunities in Disruption. With sound fundamentals and its out-the-box thinking, Everbright has consistently delivered winning plays. TABLE OF CONTENTS 8 Company Overview 10 2018 Business Development Highlights 14 2018 Review 26 Chairman’s Statement 28 Management Discussion and Analysis 46 Environmental, Social and Governance Report 76 Corporate Governance Report 100 Risk Management Report 108 Directors’ Report 122 Directors and Senior Management FINANCIAL SECTION 127 Independent Auditor’s Report 133 Consolidated Statement of Profit or Loss 134 Consolidated Statement of Comprehensive Income 135 Consolidated Statement of Financial Position 137 139 Consolidated Statement of Changes in Equity Notes to the Financial Statements 138 222 Consolidated Statement of Cash Flows Financial Summary 223 Particulars of Major Properties 224 Corporate Information SOLIDSOLID FUNDAMENTALS In 2018, the global economy experienced a tumultuous year with increased market uncertainties and depressed sentiment. Even in the face of a sector-wide downturn in private equity, however, China Everbright Limited’s core businesses delivered a solid performance, showcasing its core competencies in cross-border investment and asset management.
    [Show full text]
  • Employment Report
    FULL-TIME MS INTERIM EMPLOYMENT REPORT Simon Business School | University of Rochester SEE OUR SUCCESS CLASS OF 2019 EMPLOYMENT A new level of clarity. % WE ARE 90 EMPLOYMENT RATE 4 MONTHS POST UNABASHEDLY GRADUATION MSFMaster’s in Finance ANALYTICAL. SAMPLE HIRING COMPANIES: Recruiters are consistently impressed with Simon MS students’ command of a variety of Agricultural Bank of China analytical tools and recognize their strong problem-solving skills. Our Jay S. and Jeanne Bank of China Benet Career Management Center plans for your lifelong career success and works closely BlackRock, Inc. with Full-Time MS students who are seeking an internship or full-time employment. Bloomberg L.P. China Everbright Limited China Merchants Bank FULL-TIME MS CLASS OF 2019 PROFILE DIVERSITY YEARS OF WORK EXPERIENCE China Securities Co., Ltd. (CSC) FEMALE MALE China International Capital % % 0.2–2.2 Corporation Limited (MIDDLE 80%) Citigroup Inc. Deloitte 19COUNTRIES AGE 64 36 OF ORIGIN Estée Lauder Inc. 21–24 EY (MIDDLE 80%) Goldman Sachs Guotai Junan Securities PROGRAM ENROLLMENT GMAT HSBC Group Huawei Technologies Co., Ltd. 640–730 JPMorgan Chase & Co. 44 95 (MIDDLE 80%) Moody’s Investors Service, Inc. ACCOUNTANCY BUSINESS ANALYTICS “I CHOSE SIMON Morgan Stanley GPA 186 81 Procter & Gamble BECAUSE I WANTED FINANCE MARKETING PwC ANALYTICS 3.0–3.8 Standard Chartered Bank (MIDDLE 80%) TO DEVELOP AN ANALYTICAL MINDSET. The diverse student population that the school promoted was also a major draw for me.” MS CLASS OF 2019 EMPLOYMENT OUTCOMES JAMIE-HUGH BROWN ’19 Four months post graduation MS in Finance MEAN BASE SALARY FOR Citigroup Inc.
    [Show full text]
  • 光大證券股份有限公司 (The “Company”) (A Joint Stock Company Incorporated in the People’S Republic of China with Limited Liability)
    The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Application Proof, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Application Proof. Application Proof of Everbright Securities Company Limited 光大證券股份有限公司 (the “Company”) (A joint stock company incorporated in the People’s Republic of China with limited liability) WARNING The publication of this Application Proof is required by The Stock Exchange of Hong Kong Limited (the “Exchange”)/the Securities and Futures Commission (the “Commission”) solely for the purpose of providing information to the public in Hong Kong. This Application Proof is in draft form. The information contained in it is incomplete and is subject to change which can be material. By viewing this document, you acknowledge, accept and agree with the Company, its sponsor, advisers or member of the underwriting syndicate that: (a) this document is only for the purpose of providing information about the Company to the public in Hong Kong and not for any other purposes. No investment decision should be based on the information contained in this document; (b) the publication of this document or supplemental, revised or replacement pages on the Exchange’s website does not give rise to any obligation of the Company, its sponsors, advisers or members of the underwriting syndicate to proceed with
    [Show full text]
  • Full-Time MS Programs
    Full-Time MS Programs Simon Business School | University of Rochester At Simon Business School, a master’s degree is about more than a credential. It’s about a new level of clarity. MS IN MS IN MS IN MARKETING MS IN BUSINESS Unabashedly analytical. Intentionally collaborative. All the opportunities ACCOUNTANCY FINANCE ANALYTICS ANALYTICS and encouragement you need to reflect, refine, and take risks. p. 4 p. 8 p. 12 p. 16 That’s how clarity takes shape at Simon. The result: You see sharper. And you can get to the heart of any problem. COMPARE OUR MS PROGRAMS INTERNSHIP TRACK OPTION DO MORE AVAILABLE FOR ALL PROGRAMS. WITH NUMBERS MSA MSF MSMA MSBA THAN CRUNCH THEM. MS IN ACCOUNTANCY MS IN FINANCE MS IN MARKETING ANALYTICS MS IN BUSINESS ANALYTICS BUSINESS RUNS ON BIG DATA. But business also needs people PROGRAM HIGHLIGHTS PROGRAM HIGHLIGHTS PROGRAM HIGHLIGHTS PROGRAM HIGHLIGHTS who can turn that data into fresh insights and smart strategy. That’s • Positive Accounting • Quantitative Finance with • Digital Marketing Strategy • Big Data Research Concepts and Python • Pricing Analytics • Data Management for why Simon master’s degree programs are about much more than Empirical Analysis Tools • Investments • Pricing Policies Analytics giving you an impressive technical toolkit. We want to open up big • Applied Financial Statement • Risk Management • Predictive and Causal • Spreadsheet Modeling Using career possibilities for you. Analysis with Data Analytics • Options and Futures with Analytics in R Excel for MS • Academic experience Python • Consumer and Brand • Predictive Analytics qualification for Research with Python You’ll be taught by professors who are transforming finance, New York State economics, accounting, analytics, marketing, and pricing.
    [Show full text]
  • CHINA EVERBRIGHT LIMITED (Incorporated in Hong Kong with Limited Liability) (Stock Code: 165)
    Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. CHINA EVERBRIGHT LIMITED (Incorporated in Hong Kong with limited liability) (Stock Code: 165) ANNOUNCEMENT RESULTS FOR THE YEAR ENDED 31 DECEMBER 2020 The board of directors (the “Board” or the “Director(s)”) of China Everbright Limited (the “Company” or “CEL”) is pleased to announce that the consolidated results of the Company and its subsidiaries (collectively the “Group”) for the year ended 31 December 2020 together with relevant comparative figures for the previous year are as follows: CONSOLIDATED STATEMENT OF PROFIT OR LOSS For the year ended 31 December 2020 2020 2019 Note HK$’000 HK$’000 Turnover 3 22,682,402 12,617,142 Income from contracts with customers 3 540,419 611,778 Income from investments 3 4,337,695 3,724,311 Income from other sources 3 108,143 270,254 Impairment losses (193,000) (238,990) Operating expenses (1,132,230) (1,351,798) Profit from operations 3,661,027 3,015,555 Finance costs (1,062,091) (1,164,915) Share of profits less losses of associates 8 563,020 823,454 Share of profits less losses of joint ventures 9 43,300 88,713 Profit before taxation 3,205,256 2,762,807 Income tax 4 (948,118) (551,037) Profit for the year 2,257,138 2,211,770 – 1 – 2020
    [Show full text]